Daniella Beckman is Chief Financial Officer of Tango Therapeutics, Inc.. Currently has a direct ownership of 132,397 shares of TNGX, which is worth approximately $540,179. The most recent transaction as insider was on Feb 07, 2024, when has been sold 1,817 shares (Common Stock) at a price of $12.62 per share, resulting in proceeds of $22,930. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K
0% 3M change
36.9% 12M change
Total Value Held $540,179

Daniella Beckman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
SELL
Open market or private sale
$22,930 $12.62 p/Share
1,817 Reduced 1.35%
132,397 Common Stock
Feb 06 2024
SELL
Open market or private sale
$23,964 $12.56 p/Share
1,908 Reduced 1.4%
134,214 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
39,413 Added 50.0%
39,413 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
32,842 Added 25.35%
96,709 Common Stock

Also insider at

FVAM
5:01 Acquisition Corp. Financial Services
VOR
Vor Biopharma Inc. Healthcare
TBIO
Translate Bio, Inc. Healthcare
BPMC
Blueprint Medicines Corp Healthcare
UPB
Upstream Bio, Inc.
DB

Daniella Beckman

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on TNGX

Follow Tango Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

News

Receive news related to Tango Therapeutics, Inc.

Track Activities on TNGX